Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04252781

Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Not accepted

Summary

Chronic Obstructive Pulmonary Disease (COPD), , secondary to smoking, is a major public health issue with very high direct and indirect costs. The impact on the health system of undiagnosed patients, up to 70% of patients, is increasingly documented. However, systematic spirometry screening remains controversial among smokers in the absence of data to link the detection of new patients with improved management and clinical events and health goals. More generally, there is little data on the evolution of patients in real life once they have entered the care system. The premise is that with systematic screening in general medicine, it is possible to identify the evolution of newly diagnosed COPD patients, to distinguish the different possible evolutions according to the initial phenotype and the management.

Detailed description

A description of the population from which the groups or cohorts will be selected Smokers who have a screening spirometry for COPD, either in general medicine, at a pulmonologist or in the CHIC or Henri Mondor hospital respiratory function tests department. After screening, an equal number of men and women COPD will be included (150 men and 150 women). 1500 smokers will be included to reach 300 smokers with COPD.

Conditions

Interventions

TypeNameDescription
OTHERExhaustive exploration* clinical investigations * imagery * blood assessment * functional respiratory investigations * muscle function / skeletal muscle index

Timeline

Start date
2020-08-20
Primary completion
2025-01-07
Completion
2026-02-20
First posted
2020-02-05
Last updated
2025-01-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04252781. Inclusion in this directory is not an endorsement.